B Lymphocyte News and Research

RSS

Study links elevated BMI to weaker immune response post-SARS-CoV-2 infection

Researchers evaluated the impact of BMI elevation on humoral immunity levels against SARS-CoV-2.

6 Dec 2023

Targeted drug may offer a new treatment option for patients with relapsed blood cancer

A new targeted drug, studied by researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James), may offer a new treatment option for patients with blood cancers, including chronic lymphocytic leukemia (CLL) and Non-Hodgkin lymphoma (NHL) whose disease has stopped responding to standard treatments.

6 Nov 2023

Understanding variations in SARS-CoV-2 evolution and clearance by immunodeficiency status

Researchers describe the virological range of persistent SARS-CoV-2 infection in immunosuppressed individuals.

7 Aug 2023

Long-term protection unveiled: hybrid immunity guards against Omicron reinfections

Researchers evaluated the impact of SARS-CoV-2 Wuhan-Hu-1 strain (WH1) immune imprinting on antibody-based immunological responses.

26 Jun 2023

Study characterizes how the inflammatory microenvironment of adult mouse prostate changes during aging

A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 15, Issue 9, entitled, "Highly multiplexed immune profiling throughout adulthood reveals kinetics of lymphocyte infiltration in the aging mouse prostate."

24 May 2023

Study identifies ultra-broad SARS-CoV-2 neutralizing antibodies that target various spike epitopes

Researchers screened the circulating B lymphocyte repertoires of coronavirus disease 2019 convalescents and vaccines using multiplexed antigen panels.

3 Apr 2023

SARS-CoV-2 infection enhances vaccine-induced immunological memory against spike protein

Researchers assess SARS-CoV-2 spike protein-specific immunological memory among unvaccinated and vaccinated convalescents.

22 Mar 2023

SARS-CoV-2 BA.1 and BA.2 breakthrough infections likely protect against BA.4 infection

Omicron BTIs induce durable neutralizing immune responses by recalling cross-reactive and vaccine-induced memory B lymphocytes.

1 Mar 2023

Systemic immune-inflammation index: Valid predictor of coronary no-reflow phenomenon for older patients with STEMI undergoing PCI

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Coronary no-reflow phenomenon (NRP), a common adverse complication in patients with ST-segment elevation myocardial infarction (STEMI) treated by percutaneous coronary intervention (PCI), is associated with poor patient prognosis.

17 Feb 2023

Study provides insight into the immune microenvironment around Hodgkin lymphoma tumors

The most comprehensive study to date of the blood cancer, Hodgkin lymphoma, has provided fascinating insights into what tumour cells must do to survive. Researchers from the Wellcome Sanger Institute found that cancer cells use signals to attract certain types of immune cell and instruct them not to attack.

16 Feb 2023

Study highlights the interconnectedness of autoimmunity and cancer

In a recent study published in the journal Immunity, researchers reviewed the T cell response in cancer and autoimmunity to propose strategies for more effective immunotherapies.

15 Feb 2023

Delayed presentation of MIS-C following COVID-19

Researchers elucidate the pathophysiology of MIS-C and describe the probable reasons for the delayed presentation of the condition following COVID-19.

15 Feb 2023

Novel predictive index for gastric cancer prognosis

A new research paper was published in Oncotarget's Volume 14 on January 31, 2023, entitled, "Novel inflammation-combined prognostic index to predict survival outcomes in patients with gastric cancer."

15 Feb 2023

New insights into the role of T-cells during long COVID

Researchers characterize the trajectory of long COVID in patients eight months after recovering from infection.

14 Feb 2023

Casein-based diet found to protect diabetic mice against autoimmunity

Researchers studied diet-commensal microbial interactions in autoimmunity.

10 Feb 2023

A microbiota-driven mechanism underlies severity of leishmaniasis infection

In a recent study posed to the medRxiv* preprint server, researchers in Brazil and the United States investigated the probable impact of the skin microbiome microbiota on the outcomes of cutaneous leishmaniasis.

8 Feb 2023

Understanding the relationship between SARS-CoV-2 infection and periodontitis

In a recent review published in the journal International Journal of Molecular Sciences, researchers reviewed existing data on the association between periodontitis and coronavirus disease 2019 (COVID-19).

7 Feb 2023

The safety profile and the actual known adverse effects of COVID-19 vaccines in at-risk and healthy individuals

Researchers discussed the safety of COVID-19 vaccines in healthy people and patients with autoimmunity or cardiac issues.

7 Feb 2023

Recent therapeutic strategies for renal cell carcinoma and the effects of the tumor microenvironment on systemic therapy

Researchers explored the association between the human microbiome and improved renal cell carcinoma outcomes.

6 Feb 2023

Researchers identify a gene that drives T lymphocytes to exhaustion

A research group funded by the Swiss National Science Foundation has identified a gene that drives T lymphocytes to exhaustion. This opens up new approaches for more effective immunotherapies.

2 Feb 2023

B Lymphocyte News and Research

Study links elevated BMI to weaker immune response post-SARS-CoV-2 infection

Targeted drug may offer a new treatment option for patients with relapsed blood cancer

Understanding variations in SARS-CoV-2 evolution and clearance by immunodeficiency status

Long-term protection unveiled: hybrid immunity guards against Omicron reinfections

Study characterizes how the inflammatory microenvironment of adult mouse prostate changes during aging

Study identifies ultra-broad SARS-CoV-2 neutralizing antibodies that target various spike epitopes

SARS-CoV-2 infection enhances vaccine-induced immunological memory against spike protein

SARS-CoV-2 BA.1 and BA.2 breakthrough infections likely protect against BA.4 infection

Systemic immune-inflammation index: Valid predictor of coronary no-reflow phenomenon for older patients with STEMI undergoing PCI

Study provides insight into the immune microenvironment around Hodgkin lymphoma tumors

Study highlights the interconnectedness of autoimmunity and cancer

Delayed presentation of MIS-C following COVID-19

Novel predictive index for gastric cancer prognosis

New insights into the role of T-cells during long COVID

Casein-based diet found to protect diabetic mice against autoimmunity

A microbiota-driven mechanism underlies severity of leishmaniasis infection

Understanding the relationship between SARS-CoV-2 infection and periodontitis

The safety profile and the actual known adverse effects of COVID-19 vaccines in at-risk and healthy individuals

Recent therapeutic strategies for renal cell carcinoma and the effects of the tumor microenvironment on systemic therapy

Researchers identify a gene that drives T lymphocytes to exhaustion

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News